Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
86.25
+1.60 (1.89%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Globus Medical Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Globus Medical stock have an average target of 109.91, with a low estimate of 95 and a high estimate of 123. The average target predicts an increase of 27.43% from the current stock price of 86.25.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Globus Medical stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 5 | 6 | 6 |
| Buy | 5 | 5 | 4 | 4 | 3 | 3 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 14 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jun 23, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $115 | Buy | Maintains | $115 | +33.33% | Jun 22, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $115 → $100 | Buy | Maintains | $115 → $100 | +15.94% | Jun 15, 2026 |
| Barclays | Barclays | Buy Maintains $123 | Buy | Maintains | $123 | +42.61% | May 11, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 8, 2026 |
Financial Forecast
Revenue This Year
3.20B
from 2.94B
Increased by 8.98%
Revenue Next Year
3.40B
from 3.20B
Increased by 6.29%
EPS This Year
4.74
from 3.98
Increased by 19.17%
EPS Next Year
5.15
from 4.74
Increased by 8.48%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.2B | 3.5B | |
| Avg | 3.2B | 3.4B | |
| Low | 3.2B | 3.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.6% | 8.5% | |
| Avg | 9.0% | 6.3% | |
| Low | 8.6% | 5.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.78 | 5.30 | |
| Avg | 4.74 | 5.15 | |
| Low | 4.70 | 4.93 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 20.1% | 11.7% | |
| Avg | 19.2% | 8.5% | |
| Low | 18.1% | 3.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.